###begin article-title 0
Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study
###end article-title 0
###begin p 1
Conceived and designed the experiments: TT JMO JMG SB LF. Performed the experiments: AS. Analyzed the data: TT JS. Contributed reagents/materials/analysis tools: GRA AK JMO AS AC DA MYT LF. Wrote the paper: TT JS.
###end p 1
###begin p 2
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1</italic>
###xml 648 653 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS2</italic>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS3</italic>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1</italic>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 785 788 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;46</sup>
###xml 1019 1020 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1030 1032 1030 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 1065 1066 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1076 1079 1076 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;14</sup>
###xml 1245 1249 1245 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS</italic>
###xml 1386 1392 1386 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 1456 1457 1456 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1466 1468 1466 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1591 1597 1591 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 471 483 <span type="species:ncbi:9606">participants</span>
###xml 1082 1094 <span type="species:ncbi:9606">Participants</span>
Polyunsaturated fatty acids (PUFA) have a role in many physiological processes, including energy production, modulation of inflammation, and maintenance of cell membrane integrity. High plasma PUFA concentrations have been shown to have beneficial effects on cardiovascular disease and mortality. To identify genetic contributors of plasma PUFA concentrations, we conducted a genome-wide association study of plasma levels of six omega-3 and omega-6 fatty acids in 1,075 participants in the InCHIANTI study on aging. The strongest evidence for association was observed in a region of chromosome 11 that encodes three fatty acid desaturases (FADS1, FADS2, FADS3). The SNP with the most significant association was rs174537 near FADS1 in the analysis of arachidonic acid (AA; p = 5.95x10-46). Minor allele homozygotes had lower AA compared to the major allele homozygotes and rs174537 accounted for 18.6% of the additive variance in AA concentrations. This SNP was also associated with levels of eicosadienoic acid (EDA; p = 6.78x10-9) and eicosapentanoic acid (EPA; p = 1.07x10-14). Participants carrying the allele associated with higher AA, EDA, and EPA also had higher low-density lipoprotein (LDL-C) and total cholesterol levels. Outside the FADS gene cluster, the strongest region of association mapped to chromosome 6 in the region encoding an elongase of very long fatty acids 2 (ELOVL2). In this region, association was observed with EPA (rs953413; p = 1.1x10-6). The effects of rs174537 were confirmed in an independent sample of 1,076 subjects participating in the GOLDN study. The ELOVL2 SNP was associated with docosapentanoic and DHA but not with EPA in GOLDN. These findings show that polymorphisms of genes encoding enzymes in the metabolism of PUFA contribute to plasma concentrations of fatty acids.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 74 79 <span type="species:ncbi:9606">human</span>
Polyunsaturated fatty acids (PUFA) have a number of beneficial effects on human health. Plasma PUFA concentrations are determined by a combination of dietary intake and metabolic efficiency. To determine the genes involved in PUFA homeostasis, we scanned the genome for genetic variations associated with plasma PUFA concentrations. The fatty acid desaturase gene, studied in previous candidate gene association studies, was the strongest determinant of plasma PUFA. A second gene encoding a fatty acid elongase was associated with long chain PUFA. The results of this study contribute to our understanding of the genetics of PUFA homeostasis. These genetic markers may be useful tools to examine the inter-relationship between diet, genetics, and disease.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Sprecher1">[1]</xref>
###xml 756 761 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS2</italic>
###xml 777 785 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000338-g001">Figure 1</xref>
###xml 930 933 930 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Serhan1">[2]</xref>
###xml 1025 1028 1025 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Serhan1">[2]</xref>
###xml 1029 1032 1029 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Arita1">[4]</xref>
Polyunsaturated fatty acids (PUFA) refer to the class of fatty acids with multiple desaturations in the aliphatic tail. Short chain PUFA (up to 16 carbons) are synthesized endogenously by fatty acid synthase. Long chain PUFA are fatty acids of 18 carbons or more in length with two or more double bonds. Depending on the position of the first double bond proximate to the methyl end, PUFA are classified as n-6 or n-3. Long chain PUFA are either directly absorbed from food or synthesized from the two essential fatty acids linoleic acid (LA; 18:2n-6) and alpha-linolenic acid (ALA; 18:3n-3) through a series of desaturation and elongation processes [1]. The initial step in PUFA biosynthesis is the desaturation of ALA and LA by the enzyme d6-desaturase (FADS2; GeneID 9415) (Figure 1). PUFA modulate inflammatory response through a number of different mechanisms including modulation of cyclooxygenase and lipoxigenase activity [2]. Cyclooxygenase and lipoxigenase are essential for production of eicosanoids and resolvins [2]-[4]. Since n-3 and n-6 fatty acids compete for the same metabolic pathway and produce eicosanoids with differing effects, it has been theorized that the balance of the two classes of PUFA may be important in the pathogenesis of inflammatory diseases.
###end p 6
###begin title 7
The metabolic pathway of n-3 and n-6 fatty acids.
###end title 7
###begin p 8
The fatty acids examined in the study are indicated in bold. The dashed arrows indicate pathways absent in mammals.
###end p 8
###begin p 9
###xml 174 177 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Albert1">[5]</xref>
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Sun1">[7]</xref>
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Hodge1">[8]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Wang1">[10]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Tanskanen1">[11]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Silvers1">[12]</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Cherubini1">[13]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Ascherio1">[14]</xref>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Morris1">[15]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Brouwer1">[16]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Hakkarainen2">[18]</xref>
Epidemiological studies have shown that fatty acid consumption and plasma levels, in particular of the n-3 family, are associated with reduced risk of cardiovascular disease [5]-[7], diabetes [8]-[10], depression [11],[12], and dementia [13]. However, not all studies show significant associations and there has been inconsistencies in the direction of the associations especially for the n-6 acids [14],[15]. The different methods (dietary questionnaire or biomarkers) for accessing PUFA status may contribute to discrepant results [16]-[18]. The disadvantage of using dietary PUFA intake is the evidence of inaccuracies intrinsic in any reporting methods of dietary intake that plasma levels would circumvent. In addition, direct measures of PUFA reflect the cumulative effects of intake and endogenous metabolism. Dietary fatty acids can be converted into longer chain PUFA or stored for energy thus another reason for inconsistent results may be due the general lack of control for individual differences in metabolism once fatty acids are consumed.
###end p 9
###begin p 10
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS</italic>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Baylin1">[19]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Rzehak1">[21]</xref>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS</italic>
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS2</italic>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS3</italic>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1</italic>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS2</italic>
###xml 571 583 <span type="species:ncbi:9606">participants</span>
Previous studies have examined the association of genetic variants, especially polymorphisms in the FADS genes, on fatty acid concentrations in plasma and erythrocyte membranes [19]-[21]. There are 3 FADS (FADS1 [GeneID 3992] ,FADS2, and FADS3 [GeneID 3992]) clustered on chromosome 11. Variants in FADS1 and FADS2 have been consistently shown to be associated with PUFA concentrations. It is unknown whether other loci also determine fatty acid concentrations. To address this question, we conducted a genome-wide association study of plasma fatty acid concentration in participants in the InCHIANTI study.
###end p 10
###begin title 11
Results
###end title 11
###begin p 12
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000338-t001">Table 1</xref>
###xml 400 417 400 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1/FADS2/FADS3</italic>
###xml 443 451 443 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000338-g002">Figure 2</xref>
###xml 453 461 453 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000338-g003">Figure 3</xref>
###xml 463 471 463 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000338.s004">Table S1</xref>
###xml 541 544 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;46</sup>
###xml 687 689 687 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 712 715 712 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;14</sup>
###xml 754 756 754 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 778 780 778 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1038 1045 1038 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000338-t002">Table 2</xref>
###xml 1191 1204 1191 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1, FADS2,</italic>
###xml 1209 1214 1209 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS3</italic>
###xml 1289 1297 1289 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A10</italic>
###xml 1330 1333 1330 1333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHA</sub>
###xml 1343 1345 1343 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 1499 1508 1499 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000338.s001">Figure S1</xref>
###xml 1639 1648 1639 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000338.s002">Figure S2</xref>
Linoleic acid (LA) constituted the highest proportion of total fatty acids followed by arachidonic acid (AA) (Table 1) The narrow heritability was highest for AA (37.7%) followed by LA (35.9%), eicosadienoic acid (EDA, 33.3%), alpha-linolenic acid (ALA, 28.1%), eicosapentanoic acid (EPA, 24.4%), and docosahexanoic acid (DHA,12.0%). For EDA, AA, and EPA, genome-wide significant signals fell in the FADS1/FADS2/FADS3 region on chromosome 11 (Figure 2, Figure 3, Table S1). Of these, the most significant SNP was rs174537 for AA (P = 5.95x10-46), where the variant explained 18.6% of the additive variance of AA concentrations. This SNP was significantly associated with EDA (P = 6.78x10-9), and EPA (P = 1.04x10-14). The association with LA (P = 5.58x10-7) and ALA (P = 2.76x10-5) did not reach genome-wide significance, and there was no association with DHA (P = 0.3188). Presence of the minor allele (T) was associated with lower concentrations of longer chain fatty acids (EDA, AA, EPA), but with higher concentrations of LA and ALA (Table 2). With the exception of DHA, the SNPs exhibiting the strongest evidence of association with the fatty acids examined in this study mapped to the FADS1, FADS2, and FADS3 cluster. The most significant SNP for DHA was on chromosome 12 within the SLC26A10 gene (GeneID 65012, rs2277324; PDHA = 2.65x10-9). In all cases, inclusion of the most significant SNP as a covariate in the model resulted in attenuation of the effect of the other SNPs in the region (Figure S1). Accordingly, associated SNPs in this region were in significant linkage disequilibrium with each other in the InCHIANTI sample (Figure S2).
###end p 12
###begin title 13
Genome-wide scans of omega-6 fatty acid profiles in InCHIANTI study.
###end title 13
###begin p 14
Genome-wide associations of plasma linoleic acid (A), eicasadienoic acids (B) and arachidonic acid (C) with 495,343 autosomal and X chromosome SNPs that passed quality control graphed by chromosome position and -log10 p-value. The most significant variant was within the FAD1/FAD2/FAD3 cluster on chromosome 11. The genes nearby or within the SNPs that were selected for replication in GOLDN are indicated.
###end p 14
###begin title 15
Genome-wide scans of omega-3 fatty acid profiles in InCHIANTI study.
###end title 15
###begin p 16
Genome-wide associations of plasma alpha linolenic acid (A), eicosapentanoic acid (B) and docasahexanoic acid (C) with 495,343 autosomal and X chromosome SNPs that passed quality control graphed by chromosome position and -log10 p-value. The most significant variant was within the FAD1/FAD2/FAD3 cluster on chromosome 11. The genes nearby or within the SNPs that were selected for replication in GOLDN are indicated.
###end p 16
###begin title 17
Descriptive Characteristics of InCHIANTI and GOLDN study.
###end title 17
###begin p 18
Values represent mean (SD).
###end p 18
###begin p 19
Fatty acids are plasma concentrations (% total fatty acids) for InCHIANTI and erythrocytes concentration for GOLDN.
###end p 19
###begin title 20
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1</italic>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
Associations of fatty acids and plasma lipids by rs174537 (FADS1) and rs953413 (ELOVL2) in InCHIANTI and GOLDN study.
###end title 20
###begin p 21
Values represent mean (SD).
###end p 21
###begin p 22
Fatty acids are plasma concentrations (% total fatty acids) for InCHIANTI and erythrocytes concentration for GOLDN.
###end p 22
###begin p 23
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000338-t002">Table 2</xref>
To investigate whether this SNP has an effect on other cardiovascular disease risk factors, we examined the association of rs174537 with plasma lipid parameters. Significant association was observed with total cholesterol (P = 0.027) and LDL-cholesterol (P = 0.011), but not with either HDL-C (P = 0.775) or triglycerides (P = 0.862; Table 2). The minor allele homozygotes (TT) had 8 mg/dL lower total cholesterol and 9 mg/dL lower LDL-C compared with GG subjects.
###end p 23
###begin p 24
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS</italic>
###xml 368 376 368 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000338.s004">Table S1</xref>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HRH4</italic>
###xml 435 438 435 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EDA</sub>
###xml 448 450 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPARC</italic>
###xml 493 495 493 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sub>
###xml 505 507 505 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 523 529 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 553 555 553 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sub>
###xml 564 566 564 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS</italic>
###xml 764 768 764 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HRH4</italic>
###xml 781 787 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 804 812 804 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A10</italic>
###xml 1015 1021 1015 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 1086 1088 1086 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1099 1101 1099 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1103 1112 1103 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000338.s003">Figure S3</xref>
To identify other putative chromosome regions associated with fatty acid concentrations beyond the FADS cluster, we examined the top 3 non-redundant (r2<0.2) SNPs from the analysis of each fatty acid and selected the SNPs that mapped to candidate gene regions (defined as 20kb upstream of intron 1, or downstream of last exon) for replication in an independent study (Table S1). These included rs16940765 (HRH4 [GeneID 59340], chr18, PEDA = 2.18x10-6), rs17718324 (SPARC [GeneID 6678], chr5, PAA = 7.64x10-7) and rs953413 (ELOVL2 [GeneID 54898], chr6, PAA = 1.1x10-6). In the InCHIANTI study, these four SNPs most strongly associated with a specific fatty acid, unlike FADS cluster that was associated with multiple fatty acids. We noted, however that rs16940765 (HRH4), rs953413 (ELOVL2) and rs2277324 (SLC26A10) showed significant association at the 0.05 level for AA (P = 0.003), DHA (0.004), and EPA (P = 0.004) respectively. In addition, there were four SNPs (rs953413, rs1570069, rs3798719, rs7744440) in the ELOVL2 gene were associated with EPA with p values ranging from 9.51x10-5 to 1.10x10-6 (Figure S3). In total, 5 SNPs (rs174537, rs2277324, rs16940765, rs17718324, rs953413) were selected for replication.
###end p 24
###begin p 25
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS</italic>
###xml 190 197 190 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000338-t002">Table 2</xref>
###xml 197 198 197 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 725 732 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000338-t002">Table 2</xref>
In the GOLDN study, there were significant associations of FADS SNP, rs174537, with ALA, LA, AA, EPA and DHA (P<0.001) and marginal association with docosapentaenoic acid (DPA) (P = 0.068) (Table 2). As with the InCHIANTI study, presence of the T allele was associated with higher ALA and LA concentration and lower AA, EPA, DPA and DHA concentrations. Consistent with the InCHIANTI study, this SNP was associated with total cholesterol and LDL-C but not triglycerides or HDL-C. We also observed strong associations of rs953413 with docosapentanoic acid (DPA; P = 0.002) and DHA (P<0.001). The presence of the minor allele (A) was associated with lower DHA and higher DPA and higher AA compared to the minor allele carriers (Table 2). The remaining 3 SNP (rs2277324, rs16940765, rs17718324) were not associated with fatty acid concentrations in the GOLDN study (data not shown).
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS</italic>
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1</italic>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FEN1</italic>
###xml 699 706 699 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C11orf9</italic>
###xml 721 729 721 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C11orf10</italic>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS2</italic>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Schaeffer1">[20]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Rzehak1">[21]</xref>
###xml 1285 1289 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Schaeffer1">[20]</xref>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Rzehak1">[21]</xref>
###xml 1631 1632 1629 1630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1698 1700 1696 1698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1762 1766 1760 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Dixon1">[22]</xref>
###xml 1767 1771 1765 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Moffatt1">[23]</xref>
###xml 1881 1886 1879 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS1</italic>
###xml 1891 1896 1889 1894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FADS2</italic>
###xml 2030 2034 2028 2032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Cho1">[24]</xref>
The genome-wide association approach enables comprehensive examination of the genome to identify novel loci contributing to PUFA homeostasis. In addition, the significance of the genes previously reported in association with PUFA can be assessed relative to other regions in the genome. Here, we demonstrated that polymorphisms in the FADS cluster are the strongest determinants of plasma and erythrocyte fatty acid concentrations, explaining up to 18.6% of the additive variance in plasma AA levels. Consistent with prior reports, the greatest evidence of association was observed in the region containing FADS1, FEN1 (flap structure specific endonuclease, GeneID 2237), two hypothetical proteins (C11orf9 [GeneID 745], C11orf10 [GeneID 746]), and the promoter region of FADS2[20],[21]. With the exception of EDA, the direction of the association of rs174537 with plasma and erythrocyte fatty acids is consistent with previous reports. We find that there are higher levels of ALA and LA which is suggestive of an accumulation of the initial products of the PUFA metabolic pathway. The cluster of SNP ranging from rs174537 to rs509360 showed the strongest evidence for association, and contains the haplotype block previously examined in relation to plasma and erythrocyte fatty acids [20],[21]. Based on the HapMap CEU data, the r2 between rs174537 and previously reported SNPs were >/=0.8. If functional polymorphisms exist within this region, it could affect the expression of both desaturases. To this end, in a recent report of genome-wide association of global gene expression, the rs174546 that is in LD with the rs174537 (r2 = 0.99) was associated with FADS1 expression (LOD = 5, P = 1.6x10-6) but not FADS2 (LOD = 0.7, P = 0.07) in lymphoblastoid cells [22],[23]. The allele associated with higher AA showed greater expression of FADS1, consistent with our results. Since FADS1 and FADS2expression varies by tissue type, it would be of interest to examine the effect of the variant on gene expression in other cell types [24].
###end p 27
###begin p 28
###xml 233 237 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Kathiresan1">[25]</xref>
###xml 238 242 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Willer1">[26]</xref>
###xml 618 622 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-1">[27]</xref>
###xml 845 849 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Fruchart1">[28]</xref>
###xml 1002 1006 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Hertz1">[29]</xref>
###xml 1007 1011 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-VuDac2">[32]</xref>
###xml 1240 1244 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Guerin1">[33]</xref>
The T allele associated with lower AA was also associated with decreased LDL-C and total cholesterol. The association with LDL-C was also observed in a large meta-analysis of plasma lipid concentrations in approximately8500 subjects [25],[26]. In this meta-analysis, there was stronger evidence of association with high density lipoprotein (HDL-C) and triglycerides (TG), where the T allele displayed lower HDL-C and higher triglyceride concentrations. Finally, in the Welcome Trust Case-Control Consortium coronary artery disease (CAD) study, the T allele was associated with increased prevalence of CAD (P = 0.0375) [27]. The increased prevalence of CAD, low HDL-C and high TG is consistent with lower AA concentrations in the T allele carriers. Endogenous PUFA are natural ligands of peroxisome proliferator activating receptor alpha (PPARA) [28]. PPARA activation has been shown to elevate HDL-C and lower TG by inducing the expression of ApoA1, Apo-AII, lipoprotein lipase and suppressing ApoCIII [29]-[32]. Thus the low AA, EPA and EDA in the T allele carriers will results in lower PPARA activation. Under this hypothesis, we would expect the T allele carriers to display higher LDL-C since PPARA is known to enhance LDL-C clearance [33] . However, in both the InCHIANTI and GOLDN study, lower concentrations of LDL-C are observed. It is likely that there are other mechanisms by which fatty acids regulate lipoprotein homeostasis, for example through membrane fluidity. It may be possible, that the higher concentrations of linoleic and linolenic acid in the T allele carriers results in increased membrane fluidity, thus increasing LDL-receptor recycling leading to lower LDL-C.
###end p 28
###begin p 29
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL</italic>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Moon1">[34]</xref>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL</italic>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Jakobsson1">[35]</xref>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 942 945 942 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Sprecher1">[1]</xref>
###xml 947 955 947 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000338-g001">Figure 1</xref>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Leonard1">[36]</xref>
###xml 1324 1330 1324 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 1540 1544 1540 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Baylin2">[37]</xref>
###xml 1919 1925 1919 1925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 2220 2226 2220 2226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 2388 2394 2388 2394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
###xml 2427 2431 2427 2431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Dixon1">[22]</xref>
###xml 2432 2436 2432 2436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Moffatt1">[23]</xref>
###xml 1961 1967 <span type="species:ncbi:9606">humans</span>
The elongation of very long chain fatty acid (ELOVL) family genes are elongases that catalyze the rate-limiting condensation reaction resulting in the synthesis of very long chain fatty acids (VLCFA) [34]. To date, six ELOVL genes have been described. The ELOVL1, 3 and 6 are involved in synthesis of monounsaturated and saturated long chain fatty acids while ELOVL2, 4 and 5 elongate polyunsaturated fatty acids [35]. In this study, rs953413 in the ELOVL2 was the third most significant SNP in the analysis of EPA, with strong, although not genome-wide level significant association with long chain fatty acids EPA and DHA. In GOLDN, there were no significant associations of this SNP with EPA, but a significant association was observed with DPA. In mammals, two elongation steps are required for the synthesis of DHA from EPA. First, EPA is elongated to DPA, then to 24:5n-3 followed by a desaturation and retroconversion step to form DHA [1] (Figure 1). The two initial elongation steps of 20 and 22-C fatty acids are mediated by ELOVL2 [36]. The rs953413 is associated with substrate EPA (InCHIANTI), and product DPA (GOLDN) and DHA (both studies) of the EVOLV2 pathway. Plasma DPA levels were not measured in InCHIANTI, thus whether this association is also observed in this population cannot be investigated. Why the ELOVL2 SNP was not associated with EPA in GOLDN is not clear, however it may reflect the differences in fatty acid metabolism in erythrocytes versus plasma as they reflect two slightly different pools of fatty acids [37]. Plasma fatty acids reflect short term intake of fatty acids whereas erythrocyte levels reflect long term intake. Thus the different results between the plasma and erythrocyte fatty acids may reflect dietary differences between subjects in the GOLDN (USA) and the InCHIANTI study (Italy). Regardless of these differences, the results of this study suggestive of the role of ELOVL2 in the conversion of EPA to DHA in humans. The presence of the minor (A) allele was associated with higher EPA/DPA and lower DHA. If rs953413, located in intron 1, is the functional SNP (or is in LD with the functional SNP), this variant would likely be associated with lower expression of the ELOVL2 or result in a less efficient variant of the elongase resulting in decreased elongation of EPA to DHA. In lymphoblastoid cells, this SNP was not associated with ELOVL2 expression (LOD = 0.4, P = 0.2) [22],[23]. Further investigation in other cell lines and functional analysis of the different variants is warranted.
###end p 29
###begin p 30
###xml 380 386 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELOVL2</italic>
In summary, we have shown that the major loci for fatty acid concentrations in both plasma and erythrocyte membranes are in genes involved in the metabolism of PUFA. The FADS locus on chromosome 11 was the major contributor of plasma fatty acid concentrations, and thus may have implications for cardiovascular disease. In addition, we have identified a second promising locus in ELOVL2 that is involved in the homeostasis of longer chain n-3 fatty acids. Future studies should investigate the interactions between dietary intake, circulating levels of fatty acids and genetic variants on risk of diseases such as cardiovascular disease.
###end p 30
###begin title 31
Material and Methods
###end title 31
###begin title 32
Sample Description
###end title 32
###begin p 33
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Ferrucci1">[38]</xref>
###xml 580 592 <span type="species:ncbi:9606">participants</span>
The InCHIANTI study is a population-based epidemiological study aimed at evaluating factors that influence mobility in the older population living in the Chianti region of Tuscany, Italy. Details of the study have been previously reported [38]. Briefly, 1616 residents were selected from the population registry of Greve in Chianti (a rural area: 11 709 residents with 19.3% of the population greater than 65 years of age) and Bagno a Ripoli (Antella village near Florence; 4704 inhabitants, with 20.3% greater than 65 years of age). The participation rate was 90% (n = 1453) and participants ranged between 21-102 years of age. Overnight fasted blood samples were collected for genomic DNA extraction and measurement of plasma fatty acids. Genotyping was completed for 1231 subjects using the Illumina Infinium HumanHap 550 genotyping chip (ver1 and ver3 chips were used). The study protocol was approved by the Italian National Institute of Research and Care of Aging Institutional Review.
###end p 33
###begin p 34
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Epstein1">[39]</xref>
There were 85 parent-offspring pairs, 6 sib-pairs and 2 half-sibling pairs documented. We investigated any further familial relationships using IBD of 10,000 random SNPs using RELPAIR and uncovered 1 parent-offspring, 79 siblings and 13 half-sibling [39]. We utilized the correct family structure inferred from genetic data for all analyses. In addition, we identified 2 duplicated samples and removed these from the study. Sample quality was assessed using the GAINQC program (). The average genotype completeness and heterozygosity rates were 98% and 32% respectively. We excluded subjects that had less than 97% of genotyped completeness (n = 12), heterozygosity rate of less than 30% (n = 5) and misspecified sex based on heterozygosity of the X chromosome SNPs (n = 1). The final sample size used for SNP quality control was 1210.
###end p 34
###begin p 35
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Higgins1">[40]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Corella1">[41]</xref>
###xml 799 803 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Shen1">[42]</xref>
###xml 58 61 <span type="species:ncbi:9606">men</span>
###xml 66 71 <span type="species:ncbi:9606">women</span>
###xml 195 207 <span type="species:ncbi:9606">participants</span>
The confirmation study population consisted of 1120 white men and women in the United States participating in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study. The majority of participants were re-recruited from the ongoing National Heart and Lung and Blood Institutes (NHLBI) Family Heart Study (FHS) [40] in two genetically homogeneous centers (Minneapolis, MN and Salt Lake City, UT). GOLDN is part of the Program for Genetic Interactions (PROGENI) Network, a group of NIH-funded intervention studies of gene-environmental interactions. The primary aim of the GOLDN study was to characterize the genetic components of triglycerides response following a high fat meal and hypolipedemic drug, fenofibrate. Detailed study design and methodology has been previously described [41],[42].
###end p 35
###begin p 36
###xml 39 46 <span type="species:ncbi:9606">persons</span>
###xml 212 217 <span type="species:ncbi:9606">Human</span>
###xml 409 421 <span type="species:ncbi:9606">participants</span>
In the replication sample, we excluded persons with missing genotypes or extreme fatty acid values. The final data set consists of information on 1076 individuals. The protocol for this study was approved by the Human Studies Committee of Institutional Review Board at University of Minnesota, University of Utah and Tufts University/New England Medical Center. Written informed consent was obtained from all participants.
###end p 36
###begin title 37
Biochemical Measurements
###end title 37
###begin p 38
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">InCHIANTI:</italic>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Ferrucci2">[43]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Folch1">[44]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-RodriguezPalmero1">[45]</xref>
InCHIANTI: Plasma fatty acid measurement methods has been described previously [43]. Briefly, blood samples were collected in the morning after a 12-hr overnight fast. Aliquots of plasma were immediately obtained and stored at -80 C. Fatty acid methyl esters (FAME) were prepared through transesterification using Lepage and Roy's method with modification [44],[45]. Separation of FAME was carried out on an HP-6890 gas chromatograph (Hewlett- Packard, Palo Alto, CA) with a 30-m fused silica column (HP-225; Hewlett-Packard). FAMEs were identified by comparison with pure standards (NU Chek Prep, Inc., Elysian, MA). For quantitative analysis of fatty acids as methyl esters, calibration curves for FAME (ranging from C14:0 to C24:1) were prepared by adding six increasing amounts of individual FAME standards to the same amount of internal standard (C17:0; 50xg). The correlation coefficients for the calibration curves of fatty acids were in all cases higher than 0.998 in the range of concentrations studied. Fatty acid concentration was expressed as a percentage of total fatty acids. The coefficient of variation for all fatty acids was on average 1.6% for intraassay and 3.3% for interassay. HDL-C, total cholesterol and triglycerides were determined using commercial enzymatic tests (Roche Diagnostics, Mannheim, Germany). Serum low-density lipoprotein cholesterol (LDL-C) was computed with the Friedewald formula (LDL-C = total cholesterol - HDL-C - triglicerides/5).
###end p 38
###begin p 39
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GOLDN</italic>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Cao1">[46]</xref>
GOLDN: Fatty acids (FA) in erythrocyte membrane were measured following procedures described previously [46] Briefly, lipids were extracted from the erythrocyte membranes with a mixture of chloroform:methanol (2:1, v/v), collected in heptanes and injected onto a capillary Varian CP7420 100-m column with a Hewlett Packard 5890 gas chromatograph (GC) equipped with a HP6890A autosampler. The GC was configured for a single capillary column with a flame ionization detector and interfaced with HP chemstation software. The initial temperature of 190degreesC was increased to 240degreesC over 50 minutes. Fatty acid methylesters from 12:0 through 24:1n9 were separated, identified and expressed as percent of total fatty acid. Triglycerides were measured using a glycerol blanked enzymatic method (Trig/GB, Roche Diagnostics Corporation, Indianapolis, IN) and cholesterol was measured using a cholesterol esterase, cholesterol oxidase reaction (Chol R1, Roche Diagnostics Corporation) on the Roche/Hitachi 911 Automatic Analyzer (Roche Diagnostics Corporation). For HDL-cholesterol, the non-HDL-cholesterol was first precipitated with magnesium/dextran. LDL-cholesterol was measured by a homogeneous direct method (LDL Direct Liquid Select Cholesterol Reagent, Equal Diagnostics, Exton, PA).
###end p 39
###begin title 40
Assessment of Dietary Intake
###end title 40
###begin p 41
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Pisani1">[47]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Bartali1">[48]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Subar1">[49]</xref>
###xml 510 513 <span type="species:ncbi:9606">men</span>
###xml 544 549 <span type="species:ncbi:9606">women</span>
In the InCHIANTI, dietary intake was assessed using a food-frequency questionnaire (FFQ) created for the European Prospective Investigation into Cancer and nutrition (EPIC) study, and has previously been validated to provide good estimates of dietary intake in this study population [47],[48]. In GOLDN, habitual dietary intake was estimated using the validated dietary history questionnaire (DHQ) developed by the National Cancer Institute [49]. We excluded subjects that reported <800 kcal and >5500 kcal in men and <600kcal and >4500kcal in women.
###end p 41
###begin title 42
Genotyping
###end title 42
###begin p 43
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">InCHIANTI</italic>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Melzer1">[50]</xref>
InCHIANTI: Genome-wide genotyping was performed using the Illumina Infinium HumanHap550 genotyping chip (chip version 1 and 3) as previously described [50]. The SNP quality control was assessed using GAINQC. The exclusion criteria for SNPs were minor allele frequency <1% (n = 25,422), genotyping completeness <99% (n = 23,610) and Hardy Weinberg-equilibrium (HWE) <0.0001 (n = 517). 
###end p 43
###begin p 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GOLDN</italic>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
GOLDN: Five SNPs were selected for replication in the GOLDN study: rs953413, rs2277324, rs16940765, rs17718324 and rs174537. One of these, rs2277324, failed genotyping and therefore another SNP in high LD, rs923838 (r2 = 0.89 in hapmap), was used as a proxy for this SNP. DNA was extracted from blood samples and purified using commercial Puregene reagents (Gentra System, Inc.) following manufacturer's instructions. SNPs were genotyped using the 5'nuclease allelic discrimination Taqman assay with allelic specific probes on the ABI Prism 7900HT Sequence Detection System (Applies Biosystems, Foster City, Calif, USA) according to standard laboratory protocols. The primers and probes were pre-designed (the assay -on -demand) by the manufacturer (Applied Biosystem) (Assay ID: FEN_rs174537: C___2269026_10, HRH4_rs16940765: C__32711739_10, SPARC_rs17718324: C__34334455_10, ELOVL2_rs953413: C___7617198_10, rs923828: C___2022671_10).
###end p 44
###begin title 45
Statistical Analysis
###end title 45
###begin p 46
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">InCHIANTI GWAS</italic>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Pilia1">[51]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Chen1">[52]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Pilia1">[51]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Abney1">[53]</xref>
###xml 859 863 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Devlin1">[54]</xref>
###xml 922 924 922 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1191 1195 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000338-Abecasis1">[55]</xref>
InCHIANTI GWAS: Inverse normal transformation was applied to plasma fatty acid concentrations to avoid inflated type I error due to non-normality [51]. The genotypes were coded 0, 1 and 2 reflecting the number of copies of an allele being tested (additive genetic model). For X-chromosome analysis, the average phenotype of males hemizygous for a particular allele was treated assumed to match the average phenotype of females homozygous for the same allele. Association analysis was conducted by fitting simple regression test using the fastAssoc option in MERLIN [52]. Narrow heritability reflects the ratio of the trait's additive variance to the total variance [51],[53]. In all the analyses, the models were adjusted for sex, age and age squared. The genomic control method was used to control for effects of population structure and cryptic relatedness [54]. An approximate genome-wide significance threshold of 1x10-7 (approximately0.05/495343 SNPs) was used. For each fatty acid concentration, a second analysis included the most significant SNP from the first pass analysis as a covariate. Linkage disequilibrium coefficints within the region of interest were calculated using GOLD [55].
###end p 46
###begin p 47
For the other phenotypes (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol and BMI), the traits were normalized either by natural log or square root transformation when necessary. Associations for each SNP were investigated using the general linear model (GLM) procedure in SAS.
###end p 47
###begin p 48
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GOLDN:</italic>
###xml 866 867 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 287 290 <span type="species:ncbi:9606">men</span>
###xml 295 300 <span type="species:ncbi:9606">women</span>
GOLDN: Inverse normal transformation was applied to erythrocyte membrane fatty acid concentration to achieve approximate normality. For the additive model, genotype coding was based on the number of variant alleles at the polymorphic site. With no significant sex modification observed, men and women were analyzed together. We used the generalized estimating equation (GEE) linear regression with exchangeable correlation structure as implemented in the GENMOD procedure in SAS (Windows version 9.0, SAS Institute, Cary, NC) to adjust for correlated observations due to familial relationships. Potential confounding factors included study center, age, sex, BMI, smoking (never, former and current smoker), alcohol consumption (non-drinker and current drinker), physical activity, drugs for lowering cholesterol, diabetes and hypertension and hormones. A two-tailed P value of <0.05 was considered to be statistically significant.
###end p 48
###begin title 49
Supporting Information
###end title 49
###begin p 50
Q-Q plots for (A) linolenic acid, (B) eicosadienoic acid (C) arachidonic acid, (D), alpha-linolenic acid, (E), eicsapentanoic acid, and (F) docsahexanoic acid from the first analysis (red circles) and the second analysis after including the most significant SNP (blue circles).
###end p 50
###begin p 51
(0.52 MB TIF)
###end p 51
###begin p 52
Click here for additional data file.
###end p 52
###begin p 53
###xml 362 363 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The associations in the fatty acid desaturase clusters on chromosome 11 are displayed. (A) The -log10 pvalues for each fatty acid concentration within the FADS cluster on chromosome 11. The y axis is truncated at 14, the most significant SNP for arachidonic acid rs174537 at -log10 value of 45. (B) The genes that lie +/- 100kb of rs174537 and (C) pairwise LD (r2) in the region ranging from high (red), intermediate (green), to low (blue) in the InCHIANTI study.
###end p 53
###begin p 54
(0.76 MB TIF)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The associations in the elongation of very long fatty acid 2 gene are displayed. (A) The -log10 pvalues for each fatty acid concentration around the ELOVL2 gene. (B) The genes that lie +/- 100kb of rs953413 and (C) pairwise LD (r2) in the region ranging from high (red), intermediate (green), to low (blue) in the InCHIANTI study.
###end p 56
###begin p 57
(0.53 MB TIF)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
Top 10 non-redundant SNPs for each plasma fatty acid concentrations.
###end p 59
###begin p 60
(0.15 MB DOC)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
We would like to thank Dr. Eleanor Simonsick for reviewing the manuscript and Liming Liang for providing the lymphocyte expression data.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids.
###end article-title 64
###begin article-title 65
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.
###end article-title 65
###begin article-title 66
Dietary polyunsaturated fatty acids and regulation of gene transcription.
###end article-title 66
###begin article-title 67
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.
###end article-title 67
###begin article-title 68
Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease.
###end article-title 68
###begin article-title 69
###xml 86 91 <span type="species:ncbi:9606">women</span>
Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women.
###end article-title 69
###begin article-title 70
A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease.
###end article-title 70
###begin article-title 71
Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid.
###end article-title 71
###begin article-title 72
###xml 108 111 <span type="species:ncbi:9606">men</span>
Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men.
###end article-title 72
###begin article-title 73
Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study.
###end article-title 73
###begin article-title 74
Fish consumption and depressive symptoms in the general population in Finland.
###end article-title 74
###begin article-title 75
Fish consumption and self-reported physical and mental health status.
###end article-title 75
###begin article-title 76
###xml 49 56 <span type="species:ncbi:9606">persons</span>
Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study.
###end article-title 76
###begin article-title 77
###xml 94 97 <span type="species:ncbi:9606">men</span>
Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men.
###end article-title 77
###begin article-title 78
Fish consumption and cardiovascular disease in the physicians' health study: a prospective study.
###end article-title 78
###begin article-title 79
Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study.
###end article-title 79
###begin article-title 80
Is low dietary intake of omega-3 fatty acids associated with depression?
###end article-title 80
###begin article-title 81
Food and nutrient intake in relation to mental wellbeing.
###end article-title 81
###begin article-title 82
alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction.
###end article-title 82
###begin article-title 83
Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids.
###end article-title 83
###begin article-title 84
Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes.
###end article-title 84
###begin article-title 85
A genome-wide association study of global gene expression.
###end article-title 85
###begin article-title 86
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma.
###end article-title 86
###begin article-title 87
###xml 54 59 <span type="species:ncbi:9606">human</span>
Cloning, expression, and fatty acid regulation of the human delta-5 desaturase.
###end article-title 87
###begin article-title 88
###xml 129 135 <span type="species:ncbi:9606">humans</span>
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
###end article-title 88
###begin article-title 89
Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
###end article-title 89
###begin article-title 90
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 90
###begin article-title 91
Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
###end article-title 91
###begin article-title 92
Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.
###end article-title 92
###begin article-title 93
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
###end article-title 93
###begin article-title 94
###xml 18 23 <span type="species:ncbi:9606">human</span>
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
###end article-title 94
###begin article-title 95
###xml 27 32 <span type="species:ncbi:9606">human</span>
Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
###end article-title 95
###begin article-title 96
Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
###end article-title 96
###begin article-title 97
Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins.
###end article-title 97
###begin article-title 98
Fatty acid elongases in mammals: their regulation and roles in metabolism.
###end article-title 98
###begin article-title 99
Elongation of long-chain fatty acids.
###end article-title 99
###begin article-title 100
The use of fatty acid biomarkers to reflect dietary intake.
###end article-title 100
###begin article-title 101
Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.
###end article-title 101
###begin article-title 102
Improved inference of relationship for pairs of individuals.
###end article-title 102
###begin article-title 103
NHLBI Family Heart Study: objectives and design.
###end article-title 103
###begin article-title 104
The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study.
###end article-title 104
###begin article-title 105
Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: The GOLDN Study.
###end article-title 105
###begin article-title 106
Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.
###end article-title 106
###begin article-title 107
A simple method for the isolation and purification of total lipides from animal tissues.
###end article-title 107
###begin article-title 108
Comparison of two methods for the determination of fatty acid profiles in plasma and erythrocytes.
###end article-title 108
###begin article-title 109
Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.
###end article-title 109
###begin article-title 110
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres.
###end article-title 110
###begin article-title 111
Dietary intake estimated using different methods in two Italian older populations.
###end article-title 111
###begin article-title 112
Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study.
###end article-title 112
###begin article-title 113
A genome-wide association study identifies protein quantitative trait loci (pQTLs).
###end article-title 113
###begin article-title 114
Heritability of cardiovascular and personality traits in 6,148 Sardinians.
###end article-title 114
###begin article-title 115
Family-based association tests for genomewide association scans.
###end article-title 115
###begin article-title 116
Broad and narrow heritabilities of quantitative traits in a founder population.
###end article-title 116
###begin article-title 117
Genomic control for association studies.
###end article-title 117
###begin article-title 118
GOLD-graphical overview of linkage disequilibrium.
###end article-title 118
###begin p 119
The authors have declared that no competing interests exist.
###end p 119
###begin p 120
This study was supported in part by the R&D contract with MedStar Research Institute, the Intramural Research Program of the NIH, National Institute on Aging and by National Heart, Lung, and Blood Institute Grant U01 HL72524, Genetic and Environmental Determinants of Triglycerides; Grants HL-54776 and DK075030, and by contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture Research Service.
###end p 120

